AAKAAR MEDICAL TECHNO LTD vs MARICO LIMITED

A side-by-side comparison of AAKAAR MEDICAL TECHNO LTD (AAKAAR) and MARICO LIMITED (MARICO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, MARICO LIMITED leads AAKAAR vs MARICO on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth20
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

13.54
P/E ratio
61.22
1.77
P/B ratio
19.14
0.00%
Dividend yield
0.48%
₹4.69
EPS
₹13.57

Profitability

MARICO takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

12.17%
Return on equity
43.00%
13.93%
Return on capital
47.00%
15.40%
EBITDA margin
17.00%
9.92%
Net margin
13.32%

Growth

AAKAAR takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

26.88%
Revenue CAGR (3Y)
11.71%
45.63%
Profit CAGR (3Y)
11.10%

Size & financial health

MARICO takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹92 Cr
Market cap
₹1.08L Cr
₹67 Cr
Revenue
₹13,611 Cr
₹7 Cr
Net profit
₹1,813 Cr
0.34
Debt / equity
0.03
AAKAAR MEDICAL TECHNO LTD
  • + ["Company has delivered good profit growth of 65.2% CAGR over last 5 years"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has high debtors of 203 days.", "Working capital days have increased from 130 days to 199 days"]
MARICO LIMITED
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 40.9%", "Company has been maintaining a healthy dividend payout of 65.1%"]
  • ["Stock is trading at 25.6 times its book value", "The company has delivered a poor sales growth of 11.1% over past five years."]
AAKAAR MEDICAL TECHNO LTD full analysis MARICO LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.